Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1945 of 5804
-
New imaging technique could reveal hidden clot sources in stroke
Knowledge-focused Recruiting nowIschaemic stroke is usually due to occlusion of a cerebral artery by thrombus. However, it is often difficult to identify the source of thrombus, or to confirm thrombus as a cause of ischaemic stroke. Moreover, it is debated whether thrombosis plays any role in certain types of s…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Robot suit helps MS patients walk better?
Symptom relief CompletedThis trial is a prospective, randomized, rater-blinded study (cRHB (N=30) vs RAGT (N=30)). For the control group, this protocol includes 24 one-hour sessions of cRHB training during 8 weeks three times per week, under the supervision of a qualified rehab team. For the interventi…
Phase: NA • Sponsor: Multiple Sclerosis Center of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New radioactive tracer could sharpen breast cancer scans
Diagnosis OngoingThis phase II trial tests whether \[18F\]FluorThanatrace by positron emission tomography (PET)/computed tomography (CT) can improve imaging techniques in patients with breast cancer undergoing a standard of care biopsy or surgery. \[18F\]FluorThanatrace is a new radioactive trace…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Bubble ultrasound could spot type 1 diabetes before it strikes
Knowledge-focused Recruiting nowThe overall goal of this study is to develop and test a novel method involving ultrasound imaging, in order to detect the development of type 1 diabetes. In this study the investigators will first establish a standard operating procedure for measuring pancreas blood flow speed an…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can yoga and physical therapy help ease back pain and cut opioid use?
Symptom relief Recruiting nowThis is a pragmatic, open label, randomized controlled trial with 1:1:1 allocation to 12 weeks of: (1) onsite yoga at opioid treatment programs (OTPs), (2) onsite physical therapy (PT) at OTPs, or (3) treatment as usual (TAU). Participants will be 180 individuals with chronic bac…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New pill could ease rare muscle disease
Disease control CompletedThe purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered GLPG3667 once daily for 24 weeks in adult participants with dermatomyositis (DM), followed by an open-label extension (OLE) period …
Phase: PHASE2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Tech-Powered weight loss program aims to cut cancer risk
Disease control OngoingThe study aims to randomize 250 participants to 1 of 2 arms: a.) an Active Intervention Group (based on the Look AHEAD\* ILI) or b.) a Comparison Group (based on the Look AHEAD DSE Comparison group) to test the hypothesis that a multicomponent, multilevel behavioral weight loss i…
Phase: NA • Sponsor: University of Tennessee • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New female-focused therapy aims to curb alcohol misuse in women veterans
Symptom relief OngoingThe purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New cancer injection shows promise in early trial
Disease control Completed: A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients with Malignant Solid Tumors
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Anti-aging pill? singapore trial tests AKG on biological age
Knowledge-focused OngoingGeroscience is an emerging interdisciplinary field of study in gerontological sciences. With emphasis on understanding the mechanistic drivers of aging, it seeks translational approaches that could eventually be applied to improve human healthspan and delay age-associated chronic…
Phase: PHASE2 • Sponsor: National University of Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could an immune checkpoint drug slow Alzheimer's? early trial begins
Disease control CompletedThis is a randomized, double-blind, placebo-controlled first-in-human, Phase 1, safety, tolerability, pharmacokinetic (PK) and preliminary exploratory activity study of escalating multiple intravenous (IV) doses of IBC-Ab002 in persons with early Alzheimer's disease. The study wi…
Phase: PHASE1 • Sponsor: Immunobrain Checkpoint • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New combo pill tackles blood pressure and cholesterol at once
Disease control CompletedThis study aims to evaluate the efficacy and safety of co-administration of DWC202206 and DWC202207 in patients with concomitant hypertension and hyperlipidemia.
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Dream control: a new behavioral approach to tame narcolepsy nightmares
Symptom relief CompletedThe goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) t…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Real-World data shows Mavacamten's impact on heart condition
Disease control CompletedThe purpose of this study is to evaluate the real-world outcomes of individuals diagnosed with obstructive hypertrophic cardiomyopathy (oHCM) treated with mavacamten at the Hospital of The University of Pennsylvania in the US
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 15:36 UTC
-
Smartwatch coaching eases Runner's knee in small trial
Symptom relief CompletedPatellofemoral pain (PFP) is the most common running-related overuse injury, with prevalence up to 17% among runners. Increased patellofemoral joint stress (PFJS) is a major biomechanical contributor to PFP. Traditional strengthening exercises improve function but do not alter ru…
Phase: NA • Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jun 26, 2026 17:46 UTC
-
New eye drops aim to replace reading glasses – but are they safe Long-Term?
Disease control CompletedSafety Study of the Long-Term Safety of LNZ100 \& LNZ101 in Presbyopic Subjects
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New HIV pill combo aims to keep virus suppressed with just one daily tablet
Disease control OngoingThe primary objectives of this study are to evaluate the safety and tolerability of a switch to Doravirine/Islatravir (DOR/ISL) compared with continued baseline antiretroviral therapy (ART), through Week 48; and to evaluate the antiretroviral activity of a switch to DOR/ISL compa…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a computer program help calm anxiety in dementia?
Symptom relief OngoingThis study is a randomized controlled trial (RCT) of a remotely-delivered, technology-assisted psychotherapy program, supported by an innovative software platform for people with cognitive impairment experiencing anxiety.
Phase: NA • Sponsor: The University of Queensland • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Asthma drug benralizumab put to the test in everyday life
Disease control CompletedThis study aims to generate real-world data on the characteristics of patients receiving benralizumab to assess early PRO parameters as well as long-term treatment effects in the Gulf cooperative council (Kingdom of Saudi Arabia, Kuwait, United Arab Emirates, Oman, and Qatar), La…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Which bariatric surgery wins? new trial pits SASI bypass against sleeve gastrectomy
Disease control Recruiting nowThis study will compare two bariatric surgical interventions in terms of weight loss, gastroesophageal reflux, and effects on obesity-related comorbid conditions in morbidly obese patients.
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC